Avat Xavier's Form 4 filing
Capricor Therapeutics, Inc. (CAPR) · filed Jul 7, 2022
- Accession no.
- 0001415889-22-007544
- Filed
- Jul 7, 2022
- Trade date
- Jun 29-Jul 6, 2022
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.32K. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Avat XavierCIK 0001931345 | Officer (CHIEF BUSINESS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2022 | Common Stock | PPurchaseAcquired | +1,500 | $3.76 | +$5,640 | 2,000 | Direct | |
| Jul 6, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $3.68 | +$3,680 | 3,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.